Proactive: Race Oncology key asset RC220 passes milestone with manufactured batch confirmed for human IV useLikeFollowSharehttps://www.proactiveinvestors.com.au/companies/news/1043936/race-oncology-...Share your feedbackQuestions (0)Post questionYour question will be sent privately to Racura Oncology. The company may choose to make this question public.Start the conversationAsk Racura Oncology a question about this update.DiscoverShare your feedbackDiscover
